US Edition
Recent Research Analysts’ Ratings Changes for Merck & Co., Inc. (MRK)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Recent Research Analysts’ Ratings Changes for Merck & Co., Inc. (MRK)
Merck & Co., Inc. (NYSE: MRK) recently received a number of ratings updates from brokerages and research firms: 2/25/2026 – Merck & Co., Inc. is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $142.00 price target on the stock. 2/20/2026 – Merck & Co., Inc. is now covered by […]
[pic1 - JEFFERIES START ALZCHEM WITH 'BUY' - OBJECTIVE 190 EUR- UBS HEBTS IBM ON 'NEUTRAL' - OBJECTIVE 236 USD- RBC START PFISER WITH 'INDERPERFORM' - RBC START BRISTOL-MYERS SQUIBB WITH 'SECTOR PERFORM' - RBC START MERCK & CO WITH 'OUTPERFORM' - RBC START ABBVEY WITH 'OUTPERFORM' - RBC START ELI LILLY WITH 'OUTPERFORM' - GOLDMAN SENCT OBJECTIVE FOR HP INC AT 16 (21) USD - 'SELL'- BOFA SENCT OBJECTIVE FOR HP INC AT 16 () USD - 'UNDERPERFORM' - '…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
